Guelfi Sophie, Duffau Hugues, Bauchet Luc, Rothhut Bernard, Hugnot Jean-Philippe
INSERM U1051, Institut des Neurosciences de Montpellier, Hôpital St Eloi, 80 Avenue Augustin Fliche, 34091 Montpellier Cedex 05, France; Université Montpellier 2, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France.
INSERM U1051, Institut des Neurosciences de Montpellier, Hôpital St Eloi, 80 Avenue Augustin Fliche, 34091 Montpellier Cedex 05, France; CHU Montpellier, Hôpital Gui de Chauliac, 80 Avenue Augustin Fliche, 34295 Montpellier, France.
Stem Cells Int. 2016;2016:2759403. doi: 10.1155/2016/2759403. Epub 2016 Sep 22.
Glioblastomas are devastating and extensively vascularized brain tumors from which glioblastoma stem-like cells (GSCs) have been isolated by many groups. These cells have a high tumorigenic potential and the capacity to generate heterogeneous phenotypes. There is growing evidence to support the possibility that these cells are derived from the accumulation of mutations in adult neural stem cells (NSCs) as well as in oligodendrocyte progenitors. It was recently reported that GSCs could transdifferentiate into endothelial-like and pericyte-like cells both and , notably under the influence of Notch and TGF signaling pathways. Vascular cells derived from GBM cells were also observed directly in patient samples. These results could lead to new directions for designing original therapeutic approaches against GBM neovascularization but this specific reprogramming requires further molecular investigations. Transdifferentiation of nontumoral neural stem cells into vascular cells has also been described and conversely vascular cells may generate neural stem cells. In this review, we present and discuss these recent data. As some of them appear controversial, further validation will be needed using new technical approaches such as high throughput profiling and functional analyses to avoid experimental pitfalls and misinterpretations.
胶质母细胞瘤是一种具有破坏性且血管丰富的脑肿瘤,许多研究小组已从其中分离出胶质母细胞瘤干细胞(GSCs)。这些细胞具有很高的致瘤潜力和产生异质性表型的能力。越来越多的证据支持这样一种可能性,即这些细胞源自成年神经干细胞(NSCs)以及少突胶质细胞前体细胞中突变的积累。最近有报道称,GSCs能够转分化为内皮样细胞和周细胞样细胞,尤其是在Notch和TGF信号通路的影响下。在患者样本中也直接观察到了源自GBM细胞的血管细胞。这些结果可能为设计针对GBM血管生成的原创性治疗方法带来新方向,但这种特定的重编程需要进一步的分子研究。非肿瘤性神经干细胞向血管细胞的转分化也有相关描述,反之,血管细胞也可能产生神经干细胞。在本综述中,我们展示并讨论了这些最新数据。由于其中一些数据存在争议,因此需要使用高通量分析和功能分析等新技术方法进行进一步验证,以避免实验陷阱和错误解读。